KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Cash from Financing Activities (2017 - 2026)

Johnson & Johnson's Cash from Financing Activities history spans 18 years, with the latest figure at $530.0 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 94.91% to $530.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$15.4 billion, a 328.81% decrease, with the full-year FY2025 number at -$5.5 billion, down 76.85% from a year prior.
  • Cash from Financing Activities hit $530.0 million in Q1 2026 for Johnson & Johnson, up from -$1.4 billion in the prior quarter.
  • Over the last five years, Cash from Financing Activities for JNJ hit a ceiling of $10.4 billion in Q1 2025 and a floor of -$11.3 billion in Q4 2023.
  • Historically, Cash from Financing Activities has averaged -$1.8 billion across 5 years, with a median of -$1.4 billion in 2025.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 367.53% in 2023 and later skyrocketed 1808.79% in 2025.
  • Tracing JNJ's Cash from Financing Activities over 5 years: stood at -$4.4 billion in 2022, then decreased by 6.16% to -$4.7 billion in 2023, then skyrocketed by 71.21% to -$1.3 billion in 2024, then dropped by 2.16% to -$1.4 billion in 2025, then surged by 138.71% to $530.0 million in 2026.
  • Business Quant data shows Cash from Financing Activities for JNJ at $530.0 million in Q1 2026, -$1.4 billion in Q4 2025, and -$8.9 billion in Q3 2025.